AU650150B2 - Novel endopeptidase - Google Patents

Novel endopeptidase Download PDF

Info

Publication number
AU650150B2
AU650150B2 AU19004/92A AU1900492A AU650150B2 AU 650150 B2 AU650150 B2 AU 650150B2 AU 19004/92 A AU19004/92 A AU 19004/92A AU 1900492 A AU1900492 A AU 1900492A AU 650150 B2 AU650150 B2 AU 650150B2
Authority
AU
Australia
Prior art keywords
endopeptidase
amino acids
seq
lys
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU19004/92A
Other languages
English (en)
Other versions
AU1900492A (en
Inventor
Nicole M Resnick
Michael A Zasloff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital of Philadelphia CHOP
Original Assignee
Childrens Hospital of Philadelphia CHOP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital of Philadelphia CHOP filed Critical Childrens Hospital of Philadelphia CHOP
Publication of AU1900492A publication Critical patent/AU1900492A/en
Application granted granted Critical
Publication of AU650150B2 publication Critical patent/AU650150B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6416—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU19004/92A 1991-04-12 1992-04-10 Novel endopeptidase Ceased AU650150B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68572391A 1991-04-12 1991-04-12
PCT/US1992/002959 WO1992018516A1 (en) 1991-04-12 1992-04-10 Novel endopeptidase
US685723 1996-07-24

Publications (2)

Publication Number Publication Date
AU1900492A AU1900492A (en) 1992-11-17
AU650150B2 true AU650150B2 (en) 1994-06-09

Family

ID=24753415

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19004/92A Ceased AU650150B2 (en) 1991-04-12 1992-04-10 Novel endopeptidase

Country Status (8)

Country Link
US (1) US5518912A (online.php)
EP (1) EP0533913A1 (online.php)
JP (1) JPH06500699A (online.php)
AU (1) AU650150B2 (online.php)
CA (1) CA2083702A1 (online.php)
IL (1) IL101573A0 (online.php)
NZ (1) NZ242341A (online.php)
WO (1) WO1992018516A1 (online.php)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0029373D0 (en) * 2000-12-01 2001-01-17 Regma Biotechnologies Ltd Screening method
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
US7439319B2 (en) * 2001-09-14 2008-10-21 Burnham Institute For Medical Research Selective substrates for matrix metalloproteinases
US20030143664A1 (en) * 2001-12-03 2003-07-31 Diversa Corporation Products of manufacture and processes for peptide synthesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002871A (en) * 1986-08-18 1991-03-26 The Coca-Cola Company Enzymatic membrane method for the synthesis and separation of peptides

Also Published As

Publication number Publication date
JPH06500699A (ja) 1994-01-27
EP0533913A1 (en) 1993-03-31
IL101573A0 (en) 1992-12-30
CA2083702A1 (en) 1992-10-13
NZ242341A (en) 1993-07-27
US5518912A (en) 1996-05-21
AU1900492A (en) 1992-11-17
EP0533913A4 (online.php) 1994-03-23
WO1992018516A1 (en) 1992-10-29

Similar Documents

Publication Publication Date Title
Thomas et al. Kex2-like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: evidence for a common core of neuroendocrine processing enzymes.
Resnick et al. A novel endopeptidase from Xenopus that recognizes α-helical secondary structure
Boman et al. Chemical synthesis and enzymic processing of precursor forms of cecropins A and B
AU693815B2 (en) Enzymatic method for modification of recombinant polypeptides
KR100191697B1 (ko) 염기성 섬유아세포 성장 인자의 효소적 제조방법
EP0621340A1 (en) Product and process for the production and purification of recombinant polypeptides
Nagasawa et al. Determination of the cleavage site involved in C-terminal processing of penicillin-binding protein 3 of Escherichia coli
EP0205475B1 (en) Recombinant methods for production of serine protease inhibitors and dna sequences useful for same
JP4504014B2 (ja) インスリン分泌性ｇｌｐ−１（７−３６）ポリペプチドおよび／またはｇｌｐ−１類似体を生成する方法
Kageyama et al. Processing of the precursors to neurotensin and other bioactive peptides by cathepsin E
Naider et al. Structure-Activity Relationships of the Yeast α-Facto
US6171823B1 (en) Process for producing extracellular proteins in bacteria
Shennan et al. Site-directed mutagenesis and expression of PC2 in microinjected Xenopus oocytes.
US5518912A (en) Endopeptidase
KR100659671B1 (ko) 신규한 융합단백질로부터 재조합 인슐린을 제조하는 방법
Brennan et al. Specificity of yeast KEX2 protease for variant human proalbumins is identical to the in vivo specificity of the hepatic proalbumin convertase.
Brandt et al. Complete amino acid sequence of the N-terminal extension of calf skin type III procollagen
Brennan et al. Novel human proalbumin variant with intact dibasic sequence facilitates identification of its converting enzyme
US5474913A (en) Process for the preparation of motilin-like polypeptide and expression thereof
Ledgerwood et al. Endoproteolytic processing of recombinant proalbumin variants by the yeast Kex2 protease
Diefenbach‐Jagger et al. Arg21 is the preferred kexin cleavage site in parathyroid‐hormone‐related protein
JP3518868B2 (ja) バシラスリケニフォーミス菌株から由来したアミノペプチダーゼ及び天然蛋白質の製造方法
KR20110086711A (ko) 봉입체 형성 단백질의 제조방법
US5541062A (en) Methods and compositions for preparing protein processing enzymes
EP1326880A1 (de) Verfahren zur selektiven modifizierung von peptiden und proteinen